Aadi Bioscience, Inc.
AADI
$1.91
-$0.005-0.26%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 23.84M | 24.35M | 23.26M | 21.54M | 18.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.84M | 24.35M | 23.26M | 21.54M | 18.78M |
| Cost of Revenue | 42.39M | 39.63M | 35.53M | 32.31M | 31.47M |
| Gross Profit | -18.55M | -15.28M | -12.27M | -10.77M | -12.69M |
| SG&A Expenses | 43.96M | 44.55M | 45.31M | 44.01M | 42.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 98.46M | 96.29M | 92.95M | 88.42M | 80.75M |
| Operating Income | -74.62M | -71.93M | -69.69M | -66.88M | -61.97M |
| Income Before Tax | -68.83M | -65.77M | -63.42M | -61.59M | -61.88M |
| Income Tax Expenses | -- | -- | -9.00K | -9.00K | 0.00 |
| Earnings from Continuing Operations | -68.83 | -65.77 | -63.41 | -61.58 | -61.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.83M | -65.77M | -63.41M | -61.58M | -61.88M |
| EBIT | -74.62M | -71.93M | -69.69M | -66.88M | -61.97M |
| EBITDA | -74.44M | -71.76M | -69.52M | -66.74M | -61.85M |
| EPS Basic | -2.55 | -2.44 | -2.36 | -2.43 | -2.64 |
| Normalized Basic EPS | -1.60 | -1.53 | -1.47 | -1.52 | -1.54 |
| EPS Diluted | -2.55 | -2.44 | -2.36 | -2.43 | -2.64 |
| Normalized Diluted EPS | -1.60 | -1.53 | -1.47 | -1.52 | -1.54 |
| Average Basic Shares Outstanding | 107.77M | 107.65M | 107.53M | 101.85M | 95.94M |
| Average Diluted Shares Outstanding | 107.77M | 107.65M | 107.53M | 101.85M | 95.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
